These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of central serous chorioretinopathy--personal experience].
    Author: Chrapek O, Rehák J.
    Journal: Cesk Slov Oftalmol; 2002 Jan; 58(1):51-6. PubMed ID: 11852556.
    Abstract:
    On a group of 18 eyes the authors evaluate their experience with medicamentous and laser therapy of central serous chorioretinopathy. They report unsatisfactory results in the group of patients treated with non-steroid antiphlogistics, resorbents, vasoprotective agents, vitamins, where they observed adherence of ablated neuroepithelium in 4 eyes on average after 5.5 weeks. But in 7 similarly treated eyes adherence of the ablation did not occur even after 4 months. The authors confirm the value of direct laser photocoagulation for reducing the period of ablation in central serous chorioretinopathy. In all 11 photocoagulations of treated eyes the ablation adhered on average after 5.2 weeks. The authors maintain that they achieved better final visual acuity and greater improvement of visual acuity in patients where the ablation period of the neuroepithelium was shorter than in patients with a prolonged course of ablation.
    [Abstract] [Full Text] [Related] [New Search]